Merck, Pfizer Rebuts China's Request For Further Price Cuts For COVID-19 Drugs – Yahoo Finance

Merck & Co Inc (NYSE: MRK) and Pfizer Inc (NYSE: PFE) have reportedly signaled that they have not agreed to a request by the Chinese authorities for deeper price cuts for COVID-19 treatments.Merck’s Lagevrio (molnupiravir) will sell in China for 1,500 yuan ($221) per bottle, local media outlet Jiemian reported, saying that’s lower than the cost in many […]

Continue reading
1 56 57 58 59 60 90